Macarena Fraile-Rodriguez
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Practical consensus document on the use of [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer.
Journal: Revista espanola de medicina nuclear e imagen molecular
Published: May 29, 2026
PSMA-PET as an emerging tool for response assessment in metastatic prostate cancer (mPC): Revolution and necessary evolution.
Journal: Revista espanola de medicina nuclear e imagen molecular
Published: December 29, 2025
PSMA-PET as an emerging tool for response assessment in metastatic prostate cancer (mPC): Revolution and necessary evolution.
Journal: Revista espanola de medicina nuclear e imagen molecular
Published: December 29, 2025
One year of key contributions by the SEMNIM Oncology Group.
Journal: Revista espanola de medicina nuclear e imagen molecular
Published: July 11, 2025
Patient-Inspired In Vitro and CFD Modeling of Hepatic Intraarterial Microballoon Interventions.
Journal: IEEE transactions on bio-medical engineering
Published: June 30, 2025
PET/CT in breast cancer.
Journal: Revista espanola de medicina nuclear e imagen molecular
Published: February 12, 2025
Spanish consensus on the diagnosis and management of adrenocortical carcinoma.
Journal: Endocrine-related cancer
Published: February 11, 2025
Association of [68Ga]Ga-PSMA-11 PET/CT Metrics with PSA Persistence Following Radical Prostatectomy in Patients with Intermediate- and High-Risk Prostate Cancer.
Journal: Diagnostics (Basel, Switzerland)
Published: December 21, 2024
[18F]FDG PET-CT in Weber-Christian Disease.
Journal: Clinical nuclear medicine
Published: September 25, 2024
Comparison of staging using [68Ga]Ga-PSMA-11 PET/CT and histopathological results in intermediate- and high-risk prostate cancer patients treated with radical prostatectomy and pelvic lymph node dissection.
Journal: Revista espanola de medicina nuclear e imagen molecular
Published: September 07, 2024
Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial.
Journal: Journal of patient-reported outcomes
Published: August 21, 2024
Last Updated: 09/26/2026